Yoshitaka Okamoto

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Allergic Rhinitis

Ejection Fraction

Replacement Therapy

Top Venues

Asia Pacific allergy

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshitaka Okamoto, Moe Kato, Kiyonori Ishii, Yumi Sato, Tomohisa Hata, Yuta Asaka
Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Immunotherapy (2023)
Chang-Keun Kim, Dong Yoon Kang, Zak Callaway, Kyoung Soo Kim, Eun Mi Kwon, Fumiya Yamaide, Taiji Nakano, Yoichi Suzuki, Yoichi Mashimo, Akira Hata, Yoshitaka Okamoto, Naoki Shimojo
Increase in eosinophil-derived neurotoxin level in school children with allergic disease. Asia Pacific allergy 12 (3) (2022)
Yoshitaka Okamoto, Kiyonori Ishii, Moe Kato, Haruna Hayashi, Tomohisa Hata
Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet: 2-year interim analysis of a specified drug-use survey. Immunotherapy 13 (16) (2021)
Tomoya Kurokawa, Takuya Nakagawa, Keisuke Matsusaka, Masaki Fukuyo, Masato Mima, Kiyoshi Misawa, Bahityar Rahmutulla, Jun-Ichiro Ikeda, Toyoyuki Hanazawa, Yoshitaka Okamoto, Atsushi Kaneda
Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer. Cancer science 111 (4) (2020)
Keiichi Koshizuka, Toyoyuki Hanazawa, Naoko Kikkawa, Takayuki Arai, Atsushi Okato, Akira Kurozumi, Mayuko Kato, Koji Katada, Yoshitaka Okamoto, Naohiko Seki
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Cancer science 108 (8) (2017)